302 related articles for article (PubMed ID: 31445119)
1. In-vitro effect of vaginal lactobacilli against group B Streptococcus.
Marziali G; Foschi C; Parolin C; Vitali B; Marangoni A
Microb Pathog; 2019 Nov; 136():103692. PubMed ID: 31445119
[TBL] [Abstract][Full Text] [Related]
2. Vaginal Lactobacilli Reduce
Foschi C; Salvo M; Cevenini R; Parolin C; Vitali B; Marangoni A
Front Cell Infect Microbiol; 2017; 7():502. PubMed ID: 29270390
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of beneficial vaginal lactobacilli on pathogens responsible for urogenital tract infections.
De Gregorio PR; Tomás MSJ; Terraf MCL; Nader-Macías MEF
J Med Microbiol; 2014 May; 63(Pt 5):685-696. PubMed ID: 24523160
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of group B streptococcus susceptibility to lactic acid bacteria strains].
Bodaszewska M; Brzychczy-Włoch M; Gosiewski T; Adamski P; Strus M; Heczko PB
Med Dosw Mikrobiol; 2010; 62(2):153-61. PubMed ID: 20873488
[TBL] [Abstract][Full Text] [Related]
5. Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.
Zárate G; Nader-Macias ME
Lett Appl Microbiol; 2006 Aug; 43(2):174-80. PubMed ID: 16869901
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect between two bacteriocin-like inhibitory substances produced by Lactobacilli Strains with inhibitory activity for Streptococcus agalactiae.
Ruíz FO; Gerbaldo G; García MJ; Giordano W; Pascual L; Barberis IL
Curr Microbiol; 2012 Apr; 64(4):349-56. PubMed ID: 22231454
[TBL] [Abstract][Full Text] [Related]
7. Preventive effect of Lactobacillus reuteri CRL1324 on Group B Streptococcus vaginal colonization in an experimental mouse model.
De Gregorio PR; Juárez Tomás MS; Leccese Terraf MC; Nader-Macías ME
J Appl Microbiol; 2015 Apr; 118(4):1034-47. PubMed ID: 25786121
[TBL] [Abstract][Full Text] [Related]
8. Lactobacillus crispatus L1: high cell density cultivation and exopolysaccharide structure characterization to highlight potentially beneficial effects against vaginal pathogens.
Donnarumma G; Molinaro A; Cimini D; De Castro C; Valli V; De Gregorio V; De Rosa M; Schiraldi C
BMC Microbiol; 2014 May; 14():137. PubMed ID: 24884965
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus salivarius K12 Limits Group B Streptococcus Vaginal Colonization.
Patras KA; Wescombe PA; Rösler B; Hale JD; Tagg JR; Doran KS
Infect Immun; 2015 Sep; 83(9):3438-44. PubMed ID: 26077762
[TBL] [Abstract][Full Text] [Related]
10. Group B Streptococcus CAMP Factor Does Not Contribute to Interactions with the Vaginal Epithelium and Is Dispensable for Vaginal Colonization in Mice.
Ballard MB; Mercado-Evans V; Marunde MG; Nwanosike H; Zulk J; Patras KA
Microbiol Spectr; 2021 Dec; 9(3):e0105821. PubMed ID: 34908468
[TBL] [Abstract][Full Text] [Related]
11. Alterations of the vaginal microbiome in healthy pregnant women positive for group B Streptococcus colonization during the third trimester.
Shabayek S; Abdellah AM; Salah M; Ramadan M; Fahmy N
BMC Microbiol; 2022 Dec; 22(1):313. PubMed ID: 36544085
[TBL] [Abstract][Full Text] [Related]
12. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model.
Breshears LM; Edwards VL; Ravel J; Peterson ML
BMC Microbiol; 2015 Dec; 15():276. PubMed ID: 26652855
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens.
Scillato M; Spitale A; Mongelli G; Privitera GF; Mangano K; Cianci A; Stefani S; Santagati M
Microbiologyopen; 2021 Feb; 10(2):e1173. PubMed ID: 33970542
[TBL] [Abstract][Full Text] [Related]
15. Rectal and Vaginal Eradication of
Martín V; Cárdenas N; Ocaña S; Marín M; Arroyo R; Beltrán D; Badiola C; Fernández L; Rodríguez JM
Nutrients; 2019 Apr; 11(4):. PubMed ID: 30974819
[No Abstract] [Full Text] [Related]
16. Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity.
Parolin C; Marangoni A; Laghi L; Foschi C; Ñahui Palomino RA; Calonghi N; Cevenini R; Vitali B
PLoS One; 2015; 10(6):e0131220. PubMed ID: 26098675
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic activities of lactobacilli against Helicobacter pylori growth and infection in human gastric epithelial cells.
Chen X; Liu XM; Tian F; Zhang Q; Zhang HP; Zhang H; Chen W
J Food Sci; 2012 Jan; 77(1):M9-14. PubMed ID: 22181017
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitor effect of vaginal lactobacilli on group B streptococci].
Açikgöz ZC; Gamberzade S; Göçer S; Ceylan P
Mikrobiyol Bul; 2005 Jan; 39(1):17-23. PubMed ID: 15900833
[TBL] [Abstract][Full Text] [Related]
19. Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms.
Giordani B; Naldi M; Croatti V; Parolin C; Erdoğan Ü; Bartolini M; Vitali B
Microb Cell Fact; 2023 Mar; 22(1):45. PubMed ID: 36890519
[TBL] [Abstract][Full Text] [Related]
20. Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: A randomized controlled trial.
Ho M; Chang YY; Chang WC; Lin HC; Wang MH; Lin WC; Chiu TH
Taiwan J Obstet Gynecol; 2016 Aug; 55(4):515-8. PubMed ID: 27590374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
